Tetraferric tricitrate decahydrate clinical trials
Also written Auryxia, KRX-0502 and ferric citrate.
A product of Ferric citrate; its studies count on that page too.
How each study uses tetraferric tricitrate decahydrate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 5 Sept 2014 · AURYXIA · NDA 205874 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
USRC Kidney Research (2) · Keryx Biopharmaceuticals (2)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Ferric citrate source
Studies
Open first, then newest update. How each study uses tetraferric tricitrate decahydrate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney DiseaseCompletedPhase 3USRC Kidney ResearchNCT05085275Written as Ferric Citrate 1 GM Oral Tablet [AURYXIA]
- Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis ParticipantsCompletedPhase 4USRC Kidney ResearchNCT04922645Written as Ferric Citrate 1 gram Oral Tablet
- KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)CompletedPhase 4Keryx BiopharmaceuticalsNCT03236246Written as KRX-0502
- A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency AnemiaCompletedPhase 2Keryx BiopharmaceuticalsNCT02128074Written as KRX-0502
Given beside what is tested · 1 — tetraferric tricitrate decahydrate is usual care or a partner of the new treatment
Codes
What other systems call tetraferric tricitrate decahydrate · ClinicalTrials.gg INT017665
- UNII (FDA) Q91187K011TETRAFERRIC TRICITRATE DECAHYDRATEConfirmed FDA, Wikidata
- Wikidata Q22075864tetraferric tricitrate decahydrateConfirmed FDA, Wikidata
- NCI Thesaurus C174880Tetraferric Tricitrate DecahydrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | Q91187K011 | TETRAFERRIC TRICITRATE DECAHYDRATE | Confirmed FDA, Wikidata |
| Wikidata | Q22075864 | tetraferric tricitrate decahydrate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174880 | Tetraferric Tricitrate Decahydrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.